Nothing Special   »   [go: up one dir, main page]

YU48396A - Zwitterionic forms of trovaphloxacine,process for preparation thereof and their pharmaceutical compositions - Google Patents

Zwitterionic forms of trovaphloxacine,process for preparation thereof and their pharmaceutical compositions

Info

Publication number
YU48396A
YU48396A YU48396A YU48396A YU48396A YU 48396 A YU48396 A YU 48396A YU 48396 A YU48396 A YU 48396A YU 48396 A YU48396 A YU 48396A YU 48396 A YU48396 A YU 48396A
Authority
YU
Yugoslavia
Prior art keywords
preparation
pharmaceutical compositions
trovaphloxacine
zwitterionic forms
zwitterionic
Prior art date
Application number
YU48396A
Other languages
Serbo-Croatian (sh)
Inventor
John Meldrum Allen Douglas
Bruning Joseph David
Norris Timothy
Original Assignee
Pfizer Inc Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc Delaware filed Critical Pfizer Inc Delaware
Publication of YU48396A publication Critical patent/YU48396A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)

Abstract

Zviterjonski oblik trovafloksacina koji ima formulu koji je izabran iz grupe koju čine njegovi nehigroskopni polimerf PI, higroskopni polimorf PII i pentahidrat, kao i postupci za njihovo dobijanje. Pronalazak se dalje odnosi na farmaceutske kompozicije koje obuhvataju jedinjenja pronalaska za lečenje bakterijskih infekcija kod sisara.A zwitterionic form of trovafloxacin having a formula selected from the group consisting of its non-hygroscopic polymorph PI, hygroscopic polymorph PII and pentahydrate, as well as methods for their preparation. The invention further relates to pharmaceutical compositions comprising the compounds of the invention for the treatment of bacterial infections in mammals.

YU48396A 1995-08-29 1996-08-28 Zwitterionic forms of trovaphloxacine,process for preparation thereof and their pharmaceutical compositions YU48396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29

Publications (1)

Publication Number Publication Date
YU48396A true YU48396A (en) 1998-12-23

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
YU48396A YU48396A (en) 1995-08-29 1996-08-28 Zwitterionic forms of trovaphloxacine,process for preparation thereof and their pharmaceutical compositions

Country Status (30)

Country Link
EP (1) EP0850060A1 (en)
JP (1) JP3188476B2 (en)
KR (1) KR100343909B1 (en)
CN (1) CN1190889A (en)
AP (1) AP636A (en)
AR (1) AR003985A1 (en)
AU (1) AU704115B2 (en)
BR (1) BR9609998A (en)
CA (1) CA2229786C (en)
CO (1) CO4480739A1 (en)
CZ (1) CZ56698A3 (en)
DZ (1) DZ2087A1 (en)
GT (1) GT199600072A (en)
HR (1) HRP960395B1 (en)
HU (1) HUP9900170A3 (en)
IL (1) IL122651A (en)
MA (1) MA23966A1 (en)
MY (1) MY113874A (en)
NO (1) NO309814B1 (en)
NZ (1) NZ312199A (en)
OA (1) OA10669A (en)
PE (1) PE12598A1 (en)
PL (1) PL325170A1 (en)
RU (1) RU2144921C1 (en)
SK (1) SK23898A3 (en)
TN (1) TNSN96109A1 (en)
TR (1) TR199800339T1 (en)
WO (1) WO1997007800A1 (en)
YU (1) YU48396A (en)
ZA (1) ZA967282B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (en) 1997-08-01 1999-01-08 Pfizer Prod Inc PARENTERAL COMPOSITIONS OF ALATROFLAXACINO
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (en) 1998-01-21 2000-09-29 Pfizer Prod Inc TROVAFLOXACINO MESYLATE TABLET
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (en) * 1998-09-03 2000-06-19 Pfizer Prod Inc PROCEDURE FOR PREPARING SALTS OF TROVAFLOXACIN FOR ADDITION OF ACIDS.
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
CN1190889A (en) 1998-08-19
SK23898A3 (en) 1999-05-07
IL122651A (en) 2000-02-17
AU6367696A (en) 1997-03-19
KR100343909B1 (en) 2003-04-10
PE12598A1 (en) 1998-03-20
MX9801664A (en) 1998-08-30
GT199600072A (en) 1998-02-14
RU2144921C1 (en) 2000-01-27
AU704115B2 (en) 1999-04-15
ZA967282B (en) 1998-03-02
NO980862D0 (en) 1998-02-27
AP9600853A0 (en) 1996-10-31
BR9609998A (en) 1999-07-06
TR199800339T1 (en) 1998-06-22
CA2229786A1 (en) 1997-03-06
IL122651A0 (en) 1998-08-16
HRP960395A2 (en) 1998-06-30
JP3188476B2 (en) 2001-07-16
AR003985A1 (en) 1998-09-30
WO1997007800A1 (en) 1997-03-06
KR19990044232A (en) 1999-06-25
MA23966A1 (en) 1997-04-01
CA2229786C (en) 2002-02-19
AP636A (en) 1998-04-09
NO980862L (en) 1998-02-27
OA10669A (en) 2000-11-06
PL325170A1 (en) 1998-07-06
HUP9900170A3 (en) 1999-11-29
MY113874A (en) 2002-06-29
NZ312199A (en) 1999-06-29
DZ2087A1 (en) 2002-07-22
CO4480739A1 (en) 1997-07-09
JPH10511692A (en) 1998-11-10
EP0850060A1 (en) 1998-07-01
HRP960395B1 (en) 2001-12-31
NO309814B1 (en) 2001-04-02
CZ56698A3 (en) 1999-02-17
HUP9900170A2 (en) 1999-05-28
TNSN96109A1 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
YU16501A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
YU18101A (en) 4-amino-supstituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
FI98460B (en) Process for the preparation of a therapeutically useful 4H-1-benzopyran-4-one derivative or a salt thereof and an intermediate useful in the process
ME00558A (en) Pyrazole derivatives for treating hiv
DE69634045D1 (en) ANTITHROMBOTIC DIAMINE
HN1998000074A (en) DERIVATIVES FROM MACROLIDES C-4 SUBSTITUTED
CY1111693T1 (en) ANTIQUE FACTORS
AR038955A1 (en) PIRIMIDINONE AND PIRIDONA SUBSTITUTED COMPOUNDS AND METHODS FOR USE
BR0111263A (en) 2-Aminocarbonyl-9h-purine derivatives
FI20115753A (en) Pharmaceutical compositions for the treatment of diseases caused by IL-6 production
BR0112395A (en) Benzothiazole Derivatives
EA200501098A1 (en) ANTIBACTERIAL AGENTS
UA44254C2 (en) DERIVATIVES OF 4- (SUBSTITUTED PHENYLAMINO) QINAZOLINE, METHOD OF THEIR PREPARATION, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION
HUP0401538A2 (en) Novel derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and pharmaceutical compositions containing same
DK0462812T3 (en) Pyran derivatives as inhibitors of 5-lipoxygenase
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
YU33401A (en) 13-membered azalides and their use as antibiotic agents
ATE268337T1 (en) C11-CARBAMATES OF ANTIBACTERIAL MACROLIDS
DK1057828T3 (en) Oral trovafloxacin suspensions
YU48396A (en) Zwitterionic forms of trovaphloxacine,process for preparation thereof and their pharmaceutical compositions
YU42098A (en) The use of olanzapine
YU37597A (en) New pyranosid derivatives
ES2076838T3 (en) NEW DERIVATIVE OF ISOINDOLINONE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
ATE271062T1 (en) MACROLIDE ANTIBIOTICS
YU48296A (en) Polymorphs of the pro-drug 6-n-(l-ala-l-ala)-trovaphloxacyne processes for the preparation thereof and their pharmaceutical comositions